Overview

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

Status:
Completed
Trial end date:
2016-11-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether apremilast is safe and effective for treating patients with psoriatic arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Celgene Corporation
Treatments:
Apremilast
Thalidomide